Lv5
1140 积分 2023-06-06 加入
The Fibroblast Growth Factor signaling pathway
5个月前
已完结
Identification of a novel FGF, FGF-21, preferentially expressed in the liver
5个月前
已完结
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024
5个月前
已完结
Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
5个月前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
5个月前
已完结
Hepatic lipid droplet homeostasis and fatty liver disease
5个月前
已完结
AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions
6个月前
已完结
皖公网安备34019202002308
